RxDoctor Payments DataLook up a doctor →

Sandeep Mashru, MD

Hematology & Oncology · Portland, ORNPI 1629053855

Payments from drug & device makers

$4,643,000in general payments, 2019–2025

Across 514 payments — averaging $9033.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1.7M
  • Merck$711K
  • AstraZeneca$334K
  • Genentech, Inc.$306K
  • EMD Serono, Inc.$290K
  • GSK$230K
  • plus $1.1M from 15 others

General payments by program year

20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,643,000 in reported general payments places this provider in the 95th percentile of 112 hematology & oncology providers in Oregon.

See all hematology & oncology providers in Oregon

Medicare billing

Part B allowed, 2024
$4,509
Medicare patients
15
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →